Perspectum has launched the first study to map how COVID-19 impacts the health of multiple organs and identify at-risk features for the virus, with detailed cross-sectional imaging and genetic studies.
This study is on the National Institute for Health Research (NIHR) Portfolio
Clinical Trials Identifier: NCT04369807
To determine the prevalence and degree of organ damage in patients recovering from COVID-19 disease, using multi-parametric magnetic resonance imaging (MRI).
The study will use outpatient MRI facilities and involve blood tests, basic physical measurements (height, weight, blood pressure) and online questionnaires.
5520 John Smith Dr, Oxford OX4 2LL, United Kingdom
Chenies Mews Imaging Centre
The Roger Williams Building, 69-75 Chenies Mews
London, WC1E 7HX, United Kingdom
Mayo Clinic (Healthcare)
15 Portland Pl, Marylebone, London W1B 1PT, United Kingdom
(Closed for Screening)
This work was supported by the National Consortium of Intelligent Medical Imaging through the Industry Strategy Challenge Fund, Innovate UK Grant 104688
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 719445